Found 16 matching trials
Bioequivalence Study of Carvedilol Tablets USP 12.5 mg Under Fasting Condition
PHASE1This is a randomized, open Label, balanced, two-treatment, two-period, two-...
Location
Accutest Research Lab (I) Pvt. Ltd.
Propranolol, Carvedilol and Rosuvastatin in the Prevention of Variceal Bleeding in Cirrhotic Portal Hypertension
PHASE2Patients with hepatic cirrhosis and previous variceal bleeding will be rand...
Location
Universidade Federal do Rio de Janeiro
Fasting Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg
PHASE1The objective of this study was to investigate the bioequivalence of Mylan'...
Location
PRACS Institute, Ltd.
Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
PHASE4The APIXABAN-PK trial is a prospective, randomized, single-blind, placebo-c...
Location
Asian Institute of Medical Sciences
Beta-blockers for Oesophageal Varices
PHASE4To determine if carvedilol reduces the rate of variceal haemorrhage in pati...
Location
Royal Victoria Hospital
A Relative Bioavailability Study of Carvedilol 12.5 mg Tablets Under Non-fasting Conditions
PHASE1To compare the rate and extent of absorption of carvedilol from a test form...
Location
Biovail Contract Research (A Division of Biovail Corporation)
Fed Study of Carvedilol Tablets 12.5 mg to Coreg® Tablets 12.5 mg
PHASE1The objective of this study was to investigate the bioequivalence of Mylan'...
Location
PRACS Institute, Ltd.
Bioequivalence Study of Carvedilol 12.5mg Tablets Under Fasting Conditions
NAThe objective of this study was to compare the single-dose oral bioavailabi...
Location
Multiple Locations
Early Primary Prophylaxis of Esophageal Varices
NAPatients of cirrhosis with portal hypertension aged 18 to 75 years who have...
Location
Institute of Liver & Biliary Sciences (ILBS)
The Efficacy and Safety of Alverine in the Treatment of Portal Hypertension in Patients With Liver Cirrhosis
PHASE2Study Overall Design:
This trial is a prospective, open-label, multicenter...
Location
Multiple Locations